VLP‐factory™ and ADDomer(©): Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display

Virus‐like particles (VLPs) play a prominent role in vaccination as safe and highly versatile alternatives to attenuated or inactivated viruses or subunit vaccines. We present here two innovations, VLP‐factory™ and ADDomer (©) , for creating VLPs displaying entire proteins or peptide epitopes as ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Sari‐Ak, Duygu, Bufton, Joshua, Gupta, Kapil, Garzoni, Frederic, Fitzgerald, Daniel, Schaffitzel, Christiane, Berger, Imre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733710/
https://www.ncbi.nlm.nih.gov/pubmed/33729713
http://dx.doi.org/10.1002/cpz1.55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733710/
https://www.ncbi.nlm.nih.gov/pubmed/33729713
http://dx.doi.org/10.1002/cpz1.55

Ejemplares similares